While the current IPO environment has created a much more positive outlook in the space and drawn significant capital from retail investors there remains a very high level of competition from entrepreneurs for those dollars in the early stage. Being able to understand the current investor landscape and how to go navigate it will dramatically increase your chances of getting in front of the right investors.
This webinar will teach you about:
Meet the Presenter:
Michael Quigley is the Director of Research for LSN in Boston, Massachusetts. He has been with the company for 2 years, researching life science investors from around the globe. In addition to managing a team of research analysts in the US and abroad, Michael is the Co-Editor of LSN’s Next Phase Newsletter, where he and his team write about their latest discoveries from the life science private investment ecosystem. Michael’s passion for the life science industry was sparked by a course he took while earning his bachelor’s degree in Economics and Finance at Bentley University. During the course, entitled The Business of Biotech, Michael quickly became aware of the massive financing needs required to get a medical product approved and into the hands of doctors and patients. This massive need for capital paired with the lack of forward-looking data available on private investors is what drew him to work in investor research for LSN.
This educational event is hosted by SecureDocs, a secure virtual data room for storing and sharing sensitive business documents, & Life Science Nation, the premiere platform for connecting life science companies to products, services, and capital.